Page last updated: 2024-10-17

guaiacol and Fatty Liver

guaiacol has been researched along with Fatty Liver in 2 studies

Guaiacol: An agent thought to have disinfectant properties and used as an expectorant. (From Martindale, The Extra Pharmacopoeia, 30th ed, p747)
methylcatechol : Any member of the class of catechols carrying one or more methyl substituents.
guaiacol : A monomethoxybenzene that consists of phenol with a methoxy substituent at the ortho position.

Fatty Liver: Lipid infiltration of the hepatic parenchymal cells resulting in a yellow-colored liver. The abnormal lipid accumulation is usually in the form of TRIGLYCERIDES, either as a single large droplet or multiple small droplets. Fatty liver is caused by an imbalance in the metabolism of FATTY ACIDS.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sim, WC1
Park, S1
Lee, KY1
Je, YT1
Yin, HQ1
Choi, YJ1
Sung, SH1
Park, SJ1
Park, HJ1
Shin, KJ1
Lee, BH1
Lee, MS1
Kim, KJ1
Kim, D1
Lee, KE1
Hwang, JK1

Other Studies

2 other studies available for guaiacol and Fatty Liver

ArticleYear
LXR-α antagonist meso-dihydroguaiaretic acid attenuates high-fat diet-induced nonalcoholic fatty liver.
    Biochemical pharmacology, 2014, Aug-15, Volume: 90, Issue:4

    Topics: Animals; Base Sequence; Cell Line, Tumor; Diet, High-Fat; DNA Primers; Fatty Liver; Guaiacol; Humans

2014
meso-Dihydroguaiaretic acid inhibits hepatic lipid accumulation by activating AMP-activated protein kinase in human HepG2 cells.
    Biological & pharmaceutical bulletin, 2011, Volume: 34, Issue:10

    Topics: Acetyl-CoA Carboxylase; AMP-Activated Protein Kinases; Cell Culture Techniques; Dose-Response Relati

2011